» Articles » PMID: 27716085

Clinical Significance of Incidental [18 F]FDG Uptake in the Gastrointestinal Tract on PET/CT Imaging: a Retrospective Cohort Study

Overview
Publisher Biomed Central
Specialty Gastroenterology
Date 2016 Oct 8
PMID 27716085
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The frequency and clinically important characteristics of incidental (18)F-fluorodeoxyglucose ([18 F]FDG) positron emission tomography (PET) uptake in the gastrointestinal tract (GIT) on PET/CT imaging in adults remain elusive.

Methods: All PET/CT reports from 1/1/2000 to 12/31/2009 at a single tertiary referral center were reviewed; clinical information was obtained from cases with incidental (18)F-FDG uptake in the GIT, with follow-up through October, 2012.

Results: Of the 41,538 PET/CT scans performed during the study period, 303 (0.7 %) had incidental GIT uptake. The most common indication for the PET/CT order was cancer staging (226 cases, 75 %), with 74 % for solid and 26 % for hematologic malignancies. Of those with solid malignancy, only 51 (17 %) had known metastatic disease. The most common site of GIT uptake was the colon, and of the 240 cases with colonic uptake, the most common areas of uptake were cecum (n = 65), sigmoid (n = 60), and ascending colon (n = 50). Investigations were pursued for the GIT uptake in 147 cases (49 %), whereas 51 % did not undergo additional studies, largely due to advanced disease. There were 73 premalignant colonic lesions diagnosed in 56 cases (tubular adenoma, n = 36; tubulovillous adenoma with low grade dysplasia, n = 27; sessile serrated adenoma, n = 4; tubulovillous adenoma with high grade dysplasia, n = 3; villous adenoma, n = 3), and 20 cases with newly diagnosed primary colon cancer. All 20 (100 %) patients with malignant colonic lesions had a focal pattern of [18 F]FDG uptake. Among cases with a known pattern of [18 F]FDG uptake, 98 % of those with premalignant lesions had focal [18 F]FDG uptake. Eighteen (90 %) of the cases with newly diagnosed colon cancer were not known to have metastatic disease of their primary tumor. Areas of incidental uptake in the ascending colon had the greatest chance (42 %) of being malignant and premalignant lesions than in any other area.

Conclusion: Focality of uptake is highly sensitive for malignant and premalignant lesions of the GIT. In patients without metastatic disease, incidental focal [18]FDG uptake in the GIT on PET/CT imaging warrants further evaluation.

Citing Articles

Definitions of Incidental [F]FDG PET/CT Findings in the Literature: A Systematic Review and Definition Proposal.

Molstrom J, Lange N, Pareek M, Thomassen A, Nielsen A, Hoilund-Carlsen P Diagnostics (Basel). 2024; 14(23).

PMID: 39682672 PMC: 11639948. DOI: 10.3390/diagnostics14232764.


Total regression of a duodenal tubulovillous adenoma after chemotherapy: results of an F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan.

Abdoul Rachid M, Li J, Zhe P Quant Imaging Med Surg. 2024; 14(10):7753-7756.

PMID: 39429573 PMC: 11485335. DOI: 10.21037/qims-23-1767.


Focal incidental colorectal fluorodeoxyglucose uptake: Should it be spotlighted?.

Lee H, Hwang K World J Clin Cases. 2024; 12(15):2466-2474.

PMID: 38817235 PMC: 11135452. DOI: 10.12998/wjcc.v12.i15.2466.


Unexpected focal fluorodeoxyglucose uptake in main organs; pass through or pass by?.

Lee H, Hwang K World J Clin Cases. 2024; 12(11):1885-1899.

PMID: 38660550 PMC: 11036514. DOI: 10.12998/wjcc.v12.i11.1885.


Assessment of water enema PET/CT: an effective imaging technique for the diagnosis of incidental colorectal F-FDG uptake.

Zhang R, Abudurexiti M, Qiu W, Huang P, Hu P, Fan W BMC Med Imaging. 2024; 24(1):11.

PMID: 38172764 PMC: 10765618. DOI: 10.1186/s12880-023-01186-0.


References
1.
Kluetz P, Meltzer C, Villemagne V, Kinahan P, Chander S, Martinelli M . Combined PET/CT Imaging in Oncology. Impact on Patient Management. Clin Positron Imaging. 2001; 3(6):223-230. DOI: 10.1016/s1095-0397(01)00055-3. View

2.
Pandit-Taskar N, Schoder H, Gonen M, Larson S, Yeung H . Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. AJR Am J Roentgenol. 2004; 183(4):1143-7. DOI: 10.2214/ajr.183.4.1831143. View

3.
Abdel-Nabi H, Doerr R, Lamonica D, Cronin V, Galantowicz P, Carbone G . Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology. 1998; 206(3):755-60. DOI: 10.1148/radiology.206.3.9494497. View

4.
Rohren E, Turkington T, Coleman R . Clinical applications of PET in oncology. Radiology. 2004; 231(2):305-32. DOI: 10.1148/radiol.2312021185. View

5.
Peng J, He Y, Xu J, Sheng J, Cai S, Zhang Z . Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study. Colorectal Dis. 2011; 13(11):e374-8. DOI: 10.1111/j.1463-1318.2011.02727.x. View